| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4556 | S-34324 | alpha2-Adrenoceptor Antagonist, Norepinephrine Transporter (NET) Inhibitor, Serotonine Transporter (SERT) Inhibitor |
|
| DCC4557 | s3i-201.1066 | Potent and selective inhibitor of constitutive Stat3 DNA-binding and transcriptional activities |
|
| DCC4558 | S3qel-1 | Novel modulator of the retrograde signaling including cellular responses to hypoxic and oxidative stress, selectively eliminating superoxide production by complex III without altering oxidative phosphorylation |
|
| DCC4559 | S-4048 | Potent inhibitor of glucose-6-phosphate translocase (G6P T1) |
|
| DCC4560 | S-49164 | Novel glucokinase (GK) activator |
|
| DCC4561 | S-50612 | Novel glucokinase (GK) activator |
|
| DCC4562 | S-73362 | Dual PPARα/γ agonist |
|
| DCC4563 | S8155-7 | Novel Analogue of SUN-B8155, acting as a cell active and functionally-relevant agonist of calcitonin receptor (CTR), inducing different Gs or arrestin activities through CTR |
|
| DCC4564 | S-8510 Phosphate | Partial benzodiazepine inverse agonist, showing antidepressant-like pharmacological activity and acting as a cognitive enhancer |
|
| DCC4565 | S-8921 | Novel ileal Na /bile acid cotransporter inhibitor |
|
| DCC4566 | Sab378 | Peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibiting gastrointestinal motility with no effect on experimental colitis in mice |
|
| DCC4567 | Safrazine Hydrochloride | Irreversible and nonselective Monoamine_oxidase_inhibitor>monoamine oxidase inhibitor (MAOI) |
|
| DCC4568 | Sag1.5 | Novel Smoothened receptor agonist |
|
| DCC4569 | Saha-bpyne | Novel clickable HDAC inhibitor, selectively labeling HDAC complex proteins |
|
| DCC4570 | Saha-obp | Novel Endogenous Reactive oxygen species (ROS)-activated HDAC inhibitor prodrug, demonstrating selective activity against multiple cancer cell lines such as HeLa, MCF-7, MDA-MB-231 and B16-F10, while remaining benign to non-cancer cells |
|
| DCC4571 | Salacinol | Natural α-glucosidase inhibitor |
|
| DCC4572 | Salazinic Acid | Natural α-glucosidase inhibitor, potently modulating Nrf 2 , NF-κB and STAT3 pathways |
|
| DCC4573 | Salbutamol | ß2-adrenoceptor agonist |
|
| DCC4574 | Salinomycin Sodium | Antibiotic, Inhibiting CD44 expression in breast cancer cells and mammary tumor growth |
|
| DCC4575 | Saliphe | Novel potent V-ATPase inhibitor, blocking viral entry |
|
| DCC4576 | Samidorphan L-malate | Opioid receptor antagonist for the treatment of alcoholism and cocaine addiction |
|
| DCC4577 | Sampangine | Natural antimicrobial and antitumor agent, inducing reactive oxygen species (ROS), and alterating heme biosynthesis |
|
| DCC4578 | Sampatrilat | Vasopeptidase or dual inhibitor of ACE and neutral endopeptidase with potential application in the treatment of hypertension and congestive heart failure |
|
| DCC4579 | Sansanmycin | Uridyl peptide antibiotic, exhibiting antibacterial activity against Mycobacterium tuberculosis H(37)Ra and Pseudomonas aeruginosa with MIC values of 10 and 12.5 mug/ml, respectively |
|
| DCC4580 | Sant-2 | Novel potent inhibitor of Shh signaling pathway |
|
| DCC4581 | Sap2-in-23h | Novel Potent Non-peptidic Inhibitor of Secreted Aspartic Protease 2 (SAP2) for the Treatment of Resistant Fungal Infections |
|
| DCC4582 | Saperconazole | Broad-spectrum antifungal agent, selective inhibiting the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes, in vitro and in vivo activity against F. pedrosoi |
|
| DCC4583 | Sar-104772 | Novel inhibitor of TAFIa (activated thrombin-activatable fibrinolysis inhibitor) |
|
| DCC4584 | Sar107375 | Novel selective and potent dual inhibitor of thrombin and factor Xa |
|
| DCC4585 | Sarafloxacin | Broad spectrum antibiotic |
|
